Silenseed Silenseed is a biopharmaceutical company developing RNA interference (RNAi)-based cancer drugs. | ![]() Puma Biotechnology Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. | ||
Founding Date | Founding Date 1999 | Founding Date 2010 | Founding Date 2015 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Modi'in-Maccabim-Re'ut, IL HQ | Locations Los Angeles, US HQ | Locations South San Francisco, US HQ San Diego, US |
Employees | Employees 4 | Employees 27214% decrease | Employees 56 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 136.8 m | Valuation ($) 2.5 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $228.4m (FY, 2025) | Revenue (est.) $218.7m (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 10.5m | Total funding raised $ 172m | Total funding raised $ 140m |

Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
View company
IDEAYA Biosciences (IDEAYA) is a developer of molecular therapies.
View company